(Press-News.org) Contact information: Dr. Oliver Brüstle
r.neuro@uni-bonn.de
49-228-688-5500
University of Bonn
Human stem cells predict efficacy of Alzheimer drugs
Researchers from the University of Bonn use reprogrammed patient neurons for drug testing
Why do certain Alzheimer medications work in animal models but not in clinical trials in humans? A research team from the University of Bonn and the biomedical enterprise LIFE & BRAIN GmbH has been able to show that results of established test methods with animal models and cell lines used up until now can hardly be translated to the processes in the human brain. Drug testing should therefore be conducted with human nerve cells, conclude the scientists. The results are published by Cell Press in the journal "Stem Cell Reports".
In the brains of Alzheimer patients, deposits form that consist essentially of beta-amyloid and are harmful to nerve cells. Scientists are therefore searching for pharmaceutical compounds that prevent the formation of these dangerous aggregates. In animal models, certain non-steroidal anti-inflammatory drugs (NSAIDs) were found to a reduced formation of harmful beta-amyloid variants. Yet, in subsequent clinical studies, these NSAIDs failed to elicit any beneficial effects.
"The reasons for these negative results have remained unclear for a long time", says Prof. Dr. Oliver Brüstle, Director of the Institute for Reconstructive Neurobiology of the University of Bonn and CEO of LIFE & BRAIN GmbH. "Remarkably, these compounds were never tested directly on the actual target cells – the human neuron", adds lead author Dr. Jerome Mertens of Prof. Brüstle's team, who now works at the Laboratory of Genetics in La Jolla (USA). This is because, so far, living human neurons have been extremely difficult to obtain. However, with the recent advances in stem cell research it has become possible to derive limitless numbers of brain cells from a small skin biopsy or other adult cell types.
Scientists transform skin cells into nerve cells
Now a research team from the Institute for Reconstructive Neurobiology and the Department of Neurology of the Bonn University Medical Center together with colleagues from the LIFE & BRAIN GmbH and the University of Leuven (Belgium) has obtained such nerve cells from humans. The researchers used skin cells from two patients with a familial form of Alzheimer's Disease to produce so-called induced pluripotent stem cells (iPS cells), by reprogramming the body's cells into a quasi-embryonic stage. They then transformed the resulting so-called "jack-of-all-trades cells" into nerve cells.
Using these human neurons, the scientists tested several compounds in the group of non-steroidal anti-inflammatory drugs. As control, the researchers used nerve cells they had obtained from iPS cells of donors who did not have the disease. Both in the nerve cells obtained from the Alzheimer patients and in the control cells, the NSAIDs that had previously tested positive in the animal models and cell lines typically used for drug screening had practically no effect: The values for the harmful beta-amyloid variants that form the feared aggregates in the brain remained unaffected when the cells were treated with clinically relevant dosages of these compounds.
Metabolic processes in animal models differ from humans
"In order to predict the efficacy of Alzheimer drugs, such tests have to be performed directly on the affected human nerve cells", concludes Prof. Brüstle's colleague Dr. Philipp Koch, who led the study. Why do NSAIDs decrease the risk of aggregate formation in animal experiments and cell lines but not in human neurons? The scientists explain this with differences in metabolic processes between these different cell types. "The results are simply not transferable", says Dr. Koch.
The scientists now hope that in the future, testing of potential drugs for the treatment of Alzheimer's disease will be increasingly conducted using neurons obtained from iPS cells of patients. "The development of a single drug takes an average of ten years", says Prof. Brüstle. "By using patient-specific nerve cells as a test system, investments by pharmaceutical companies and the tedious search for urgently needed Alzheimer medications could be greatly streamlined".
INFORMATION:
Publication: APP Processing in Human Pluripotent Stem Cell-Derived Neurons is Resistant to NSAID-Based Gamma-Secretase Modulation, Stem Cell Reports, DOI: 10.1016/j.stemcr.2013.10.011
Contact:
Prof. Dr. Oliver Brüstle
Institute for Reconstructive Neurobiology
Life & Brain Center
University of Bonn
Tel. ++49-228-6885500
E-Mail: r.neuro@uni-bonn.de
Human stem cells predict efficacy of Alzheimer drugs
Researchers from the University of Bonn use reprogrammed patient neurons for drug testing
2013-12-06
ELSE PRESS RELEASES FROM THIS DATE:
New study finds corn oil superior to extra virgin olive oil in lowering cholesterol
2013-12-06
New study finds corn oil superior to extra virgin olive oil in lowering cholesterol
Plant sterols naturally found in corn oil linked to heart health benefits
WASHINGTON, December 6, 2013 – Corn oil significantly reduces cholesterol with more favorable changes ...
Enzalutamide in prostate cancer: Hints of added benefit
2013-12-06
Enzalutamide in prostate cancer: Hints of added benefit
Longer overall survival in patients without visceral metastases / bone complications and pain progression delayed
Enzalutamide (trade name: Xtandi) has been approved since ...
Study finds parental stress linked to obesity in children
2013-12-06
Study finds parental stress linked to obesity in children
Effects on Hispanic children more pronounced
TORONTO, Dec. 6, 2013—Parental stress is linked to weight gain in children, according to a new study from St. Michael's Hospital.
The study found that children ...
What is the link between erectile dysfunction and heart disease?
2013-12-06
What is the link between erectile dysfunction and heart disease?
New Rochelle, NY, December 6, 2013—Erectile dysfunction (ED) is caused by the inability of the artery that supplies blood to the penis to expand and contract properly. The ...
Coal yields plenty of graphene quantum dots
2013-12-06
Coal yields plenty of graphene quantum dots
Rice U. scientists find simple method for producing dots in bulk from coal, coke
HOUSTON – (Dec. 6, 2013) – The prospect of turning coal into fluorescent particles may sound too good to be true, but the possibility exists, thanks ...
Graphene: Growing giants
2013-12-06
Graphene: Growing giants
Huge grains of copper promote better graphene growth
WASHINGTON D.C. Dec. 6, 2013 -- To technology insiders, graphene is a certified big deal. The one-atom thick carbon-based material elicits rhapsodic descriptions as the strongest, ...
1 percent of the population is responsible for 63 percent of violent crime convictions
2013-12-06
1 percent of the population is responsible for 63 percent of violent crime convictions
The majority of all violent crime in Sweden is committed by a small number of people. They are almost all male (92%) who early in life develops violent criminality, substance abuse ...
Frequent cell phone use linked to anxiety, lower grades and reduced happiness in students
2013-12-06
Frequent cell phone use linked to anxiety, lower grades and reduced happiness in students
Today, smartphones are central to college students' lives, keeping them constantly connected with friends, family and the Internet. Students' cell phones are rarely out of reach ...
Taking probiotics in pregnancy or giving them to infants doesn't prevent asthma
2013-12-06
Taking probiotics in pregnancy or giving them to infants doesn't prevent asthma
Taking probiotics has health benefits but preventing childhood asthma isn't one of them, shows newly published research led by medical scientists at the ...
Counting the cost of infertility treatment
2013-12-06
Counting the cost of infertility treatment
From drug therapy to IVF, out-of pocket costs can range from $900 to $19,000 per treatment cycle, report researchers in The Journal of Urology®
New York, NY, December 6, 2013 – Although the demand for infertility treatment ...
LAST 30 PRESS RELEASES:
Fat may play an important role in brain metabolism
New study finds no lasting impact of pandemic pet ownership on human well-being
New insights on genetic damage of some chemotherapies could guide future treatments with less harmful side effects
Gut microbes could protect us from toxic ‘forever chemicals’
Novel modelling links sea ice loss to Antarctic ice shelf calving events
Scientists can tell how fast you're aging from a single brain scan
U.S. uterine cancer incidence and mortality rates expected to significantly increase by 2050
Public take the lead in discovery of new exploding star
What are they vaping? Study reveals alarming surge in adolescent vaping of THC, CBD, and synthetic cannabinoids
ECMWF - delivering forecasts over 10 times faster and cutting energy usage by 1000
Brazilian neuroscientist reveals how viral infections transform the brain through microscopic detective work
Turning social fragmentation into action through discovering relatedness
Cheese may really be giving you nightmares, scientists find
Study reveals most common medical emergencies in schools
Breathable yet protective: Next-gen medical textiles with micro/nano networks
Frequency-engineered MXene supercapacitors enable efficient pulse charging in TENG–SC hybrid systems
Developed an AI-based classification system for facial pigmented lesions
Achieving 20% efficiency in halogen-free organic solar cells via isomeric additive-mediated sequential processing
New book Terraglossia reclaims language, Country and culture
The most effective diabetes drugs don't reach enough patients yet
Breast cancer risk in younger women may be influenced by hormone therapy
Strategies for staying smoke-free after rehab
Commentary questions the potential benefit of levothyroxine treatment of mild hypothyroidism during pregnancy
Study projects over 14 million preventable deaths by 2030 if USAID defunding continues
New study reveals 33% gap in transplant access for UK’s poorest children
Dysregulated epigenetic memory in early embryos offers new clues to the inheritance of polycystic ovary syndrome (PCOS)
IVF and IUI pregnancy rates remain stable across Europe, despite an increasing uptake of single embryo transfer
It takes a village: Chimpanzee babies do better when their moms have social connections
From lab to market: how renewable polymers could transform medicine
Striking increase in obesity observed among youth between 2011 and 2023
[Press-News.org] Human stem cells predict efficacy of Alzheimer drugsResearchers from the University of Bonn use reprogrammed patient neurons for drug testing